First Time Loading...

Neuronetics Inc
NASDAQ:STIM

Watchlist Manager
Neuronetics Inc Logo
Neuronetics Inc
NASDAQ:STIM
Watchlist
Price: 3.555 USD 5.49% Market Closed
Updated: May 2, 2024
Section:
 

Wall Street
Price Targets

STIM Price Targets Summary
Neuronetics Inc

Wall Street analysts forecast STIM stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for STIM is 7.14 USD with a low forecast of 6.06 USD and a high forecast of 8.4 USD.

STIM Lowest Forecast
Wall Street Target
6.06 USD
70% Upside
STIM Average Forecast
Wall Street Target
7.14 USD
101% Upside
STIM Highest Forecast
Wall Street Target
8.4 USD
136% Upside
Lowest
Price Target
6.06 USD
70% Upside
Average
Price Target
7.14 USD
101% Upside
Highest
Price Target
8.4 USD
136% Upside
Neuronetics Inc Competitors:
Price Targets
CYRX
Cryoport Inc
11% Upside
MLSS
Milestone Scientific Inc
378% Upside
TCMD
Tactile Systems Technology Inc
47% Upside
B
BIOBV
Biohit Oyj
22% Upside
CYRX
Cryoport Inc
11% Upside
MLSS
Milestone Scientific Inc
378% Upside
TCMD
Tactile Systems Technology Inc
47% Upside
B
BIOBV
Biohit Oyj
22% Upside
688575
Shenzhen YHLO Biotech Co Ltd
17% Upside
NVNO
enVVeno Medical Corp
306% Upside
KEQU
Kewaunee Scientific Corp
22% Downside
AFX
Carl Zeiss Meditec AG
14% Upside

Revenue
Forecast

Revenue Estimate
Neuronetics Inc

For the last 6 years the compound annual growth rate for Neuronetics Inc's revenue is 10%. The projected CAGR for the next 3 years is 14%.

10%
Past Growth
14%
Estimated Growth
Estimates Accuracy
-1%
Average Miss
What are analyst estimates?

Operating Income
Forecast

Operating Income Estimate
Neuronetics Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-6%
Average Miss
What are analyst estimates?

Net Income
Forecast

Net Income Estimate
Neuronetics Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-28%
Average Miss
What are analyst estimates?

See Also

Summary
STIM intrinsic value, competitors valuation, and company profile.
DCF Valuation
STIM stock valuation using Discount Cash Flow valuation method.
Relative Valuation
STIM stock valuation using valuation multiples.
Wall Street Estimates
STIM price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
STIM stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is STIM's stock price target?
Price Target
7.14 USD

According to Wall Street analysts, the average 1-year price target for STIM is 7.14 USD with a low forecast of 6.06 USD and a high forecast of 8.4 USD.

What is Neuronetics Inc's Revenue forecast?
Projected CAGR
14%

For the last 6 years the compound annual growth rate for Neuronetics Inc's revenue is 10%. The projected CAGR for the next 3 years is 14%.

ALPHA SPREAD
Join more than 133,400+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.